جست‌وجوی استاد و پژوهشگر

Mauricio Berriel Diazمشاهده پروفایل

پژوهشگر

• Energy Metabolism
• Cancer Cachexia
• Tumor Metabolism
• +۳ مورد دیگر

Mauricio Berriel Diaz is a Researcher at the Helmholtz Center Munich , serving as Deputy Director and Head of the Division Metabolism and Cancer since 2015. His work bridges energy metabolism and oncology, with a focus on systemic metabolic interactions in cancer progression and therapy. Deputy Director, Institute for Diabetes & Cancer (since 2015) Head of Division Metabolism and Cancer Research Interests: His research program investigates the interconnections between energy metabolism and cancer, particularly: Mechanisms of cancer cachexia (systemic wasting syndrome) Tumor-host metabolic interactions Lipid metabolism in obesity-related cancer progression Therapeutic targeting of tumor metabolism Systemic metabolic regulation in disease contexts Scientific Contributions: His work has expanded understanding of cancer cachexia beyond skeletal muscle loss to include roles of liver and adipose tissue metabolism, with recent publications in Journal of Cachexia, Sarcopenia and Muscle , EMBO Molecular Medicine , and Cell Metabolism . Scientific Leadership: Selected honors and editorial roles include: Associate Editor, Journal of Cachexia, Sarcopenia and Muscle (since 2018) Peer reviewer for top journals including Nature Communications and Oncogene Referee for Swiss National Science Foundation Sinergia Program (2015)

• Neuroendocrinology
• Neuroendocrine Tumors
• Translational Cancer Research
• +۴ مورد دیگر

Prof. Dr. Natalia S. Pellegata serves as Head of the Neuroendocrinology Division at the Institute for Diabetes and Cancer, Helmholtz Munich since 2016 and holds an Adjunct Professorship at the Technical University of Munich's Faculty of Medicine since 2018. With over two decades of research experience, she leads translational studies focused on neuroendocrine tumors (NETs) and cancer cachexia, leveraging unique animal models for drug discovery. Her seminal work established CDKN1B as a tumor susceptibility gene, defining MEN4 syndrome in humans through cross-species validation using the MENX rat model. Current research identifies druggable pathways including BMP signaling in pheochromocytomas and angiopoietin/Tie2 in pituitary tumors, providing clinical rationale for dual PI3K/mTOR inhibitors and anti-angiogenic therapies. Recent investigations extend into metabolic dysregulation in cancer cachexia, emphasizing lipid metabolism alterations. Publication analysis reveals consistent focus on metabolic mechanisms in tumor progression, with recurring themes in lipid metabolism (ceramides, PLA2G7), stress response pathways, and metabolic enzyme targeting across neuroendocrine and breast cancers. These studies bridge preclinical models with human pathophysiology through rigorous translational frameworks. Scientific recognition includes: Eleonore Trefftz Visiting Professorship for Women Scientists, Technical University of Dresden (2015) Her laboratory operates within major collaborative networks including CRC/TRR 205 'Adrenal Research', the European Neuroendocrine Tumor Society (ENS@T), and legacy SFB824 imaging consortia, utilizing functional imaging for in vivo therapy monitoring and preclinical drug evaluation.

• Biomedical Engineering
• Mechanical Measurements
• Energy Storage Systems
• +۴ مورد دیگر

Emanuele Rizzuto is an Associate Professor in the Department of Mechanical and Aerospace Engineering at Sapienza University of Rome. His research focuses on biomedical and industrial applications, including biomechanical measurements of muscle tissues, neuromuscular junction functionality, and energy storage systems. He leads initiatives such as the Rome Technopole 'Advanced Materials and Systems' and has secured significant grants for projects like NEST and SELFIE-CHECK. Rizzuto teaches courses in mechanical measurements, clinical diagnostics, and energy engineering. His editorial roles include guest editorships for journals like Energies and Sensors . Recent work includes innovations in hydrogen production, battery efficiency, and optical sensors for biomedical applications. Education : Industrial Engineering qualifications and National Scientific Qualification as Full Professor (2019). Research Interests : Biomedical engineering (muscle repair, neurodegenerative diseases), energy storage, and smart materials for heritage preservation. Grants : Over €500k in recent funding for energy storage, biomaterials, and ALS research. Labs/Teams : Open Lab Rome Technopole, involvement in interdisciplinary projects like CALAMITY and Counteracting neuromuscular junction dismantlement.

Joanne Reidمشاهده پروفایل

استاد

• Cancer Care
• Palliative Care
• Chronic Illness Management
• +۴ مورد دیگر

Professor Joanne Reid is a Professor of Cancer and Palliative Care at the School of Nursing and Midwifery, Queen's University Belfast (QUB), within the Faculty of Medicine, Health & Life Sciences. She leads research in cachexia across chronic illnesses (cancer, renal, cardiac) and palliative care, with international collaborations and grants (e.g., DIAdIC, Marie Curie-funded studies). Her roles include Chair of the All Ireland Institute's Palliative Care Research Network and the EAPC Research Network. Prof. Reid supervises PhD students in cachexia and healthcare interventions and chairs the INDEN Global Classroom initiative. Key research interests focus on cachexia management, palliative care guidelines, and complex interventions for patients and caregivers. Her work informs clinical practice, such as national guidelines for cancer care and interprofessional teams. Current projects include evaluating psycho-educational interventions for cachexia and moral distress in intensive care. She has over 198 publications and 17 awards, including the EDTNA/ERCA Scholarship and EAPC recognition. Leadership: Postgraduate Research Committee Chair, BMC Palliative Care Associate Editor Teaching: Evidence-Based Nursing, External Examiner at University of Chester Grants: €6.5M+ in funding from EU, NI Biobank, Puffin Trust Her research impacts policy and clinical practice, with media engagement (e.g., Irish News feature on future palliative care trends). She collaborates globally with institutions like St Vincent’s Melbourne and Mayo Clinic.

• Cancer Cachexia
• Obesity Management
• Nutritional Status in Critical Illness
• +۳ مورد دیگر

Dr Katerina Vasilaki is a Lecturer in Dietetics and Nutrition at Queen Margaret University (QMU), affiliated with the DNBS Division. She holds concurrent roles as an Honorary Lecturer at the University of Glasgow’s Surgery Section and is an Affiliate of the University of Glasgow’s School of Medicine. Her clinical background includes NHS work in obesity management, gastroenterology, and general medicine, alongside freelance dietetic consulting featured in BBC News, BBC Good Food Show, and STV. Educated at Harokopio University (BSc Dietetics, 2002), University of Glasgow (MSc in Clinical Nutrition, 2003; PhD in Micronutrient Assessment, 2010), she has held academic positions across institutions including the University of Dundee and Glasgow Caledonian University. Her research focuses on cancer cachexia, non-diet obesity approaches, and micronutrient dynamics in critical illness. Research methods include body composition analysis via BIA/CT scans, functional assessments (handgrip dynamometry), and advanced biochemical techniques for micronutrient analysis. Awards include a 2018 Health Blogger of the Year finalist nomination and a British Pancreatic Society Pump Priming Grant. Her work bridges clinical practice and academia, with collaborations extending to pancreatic cancer research and nutritional interventions in surgical/trauma settings. She leads obesity management specializations in postgraduate courses and advocates for non-diet approaches to weight management.

• Molecular Biology
• MicroRNA Regulation
• Transcription Factors
• +۴ مورد دیگر

Davide CORA' is an Associate Professor at the University of Piemonte Orientale Amedeo Avogadro , affiliated with the Department of Translational Medicine. He has held this position since at least 2023 and continues to be actively involved in research. Research Interests : Davide’s work focuses on molecular mechanisms underlying diseases such as cancer, neurodegenerative disorders, and viral infections. Key areas include microRNA regulation, transcription factors (e.g., Transcription Factor EB), bioinformatics analysis, and translational medicine applications. His research aligns with UN Sustainable Development Goals related to health and well-being, contributing to innovative solutions in medical science. Projects & Grants : He leads A computational pipeline for Alzheimer’s gut microbiota analysis (MUR-funded, 2023–2025) Role of mRNA splicing in cancer cachexia (MUR-funded, 2023–2025) and co-investigated Vitamin D’s role in preventing skeletal muscle loss (2023–ongoing) FFABR 2017–2021 foundational research funding (MIUR) Collaborations : Davide collaborates with researchers like Favero, Gagliardi, Gravina, and others, focusing on interdisciplinary projects in bioinformatics, microbiology, and oncology.

• Cardiovascular Disease Prevention
• Clinical Trial Design
• Atherosclerosis
• +۴ مورد دیگر

Dr. James Revkin is an Associate Clinical Professor at the Yale School of Medicine (Yale University), specializing in the primary and secondary prevention of cardiovascular disease . He is an expert in the design and conduct of clinical trials for cardiovascular and metabolic diseases, particularly focusing on atherosclerosis, hypertension, heart failure, obesity, and diabetes. His work emphasizes the use of vascular imaging biomarkers to evaluate pharmaceutical agents' efficacy in slowing atherosclerosis progression. Education & Training: MD, Brown University (1981) BA in Philosophy/French, Williams College (1976) Residency: Columbia-Presbyterian Medical Center (1984) Fellowship: Yale University School of Medicine (1987) Postdoctoral Trainee: Center for Bioengineering, University of Washington (1988) Research Interests: Dr. Revkin’s research focuses on clinical trial design for cardiovascular and metabolic diseases, with a particular emphasis on: Cardiovascular outcomes in patients with heart failure and cachexia Pharmacological interventions targeting growth differentiation factor-15 (GDF-15) in cancer cachexia Screening strategies for atrial fibrillation using wearable ECG monitors PCSK9 inhibitors and their role in familial hypercholesterolemia Advising & Grants: As a subject matter expert, Dr. Revkin collaborates on industry-sponsored trials and leads teams in: Phase 1b–2 clinical trials for drugs like ponsegromab Systematic reviews and meta-analyses of cancer cachexia outcomes Rationale-driven trial design for cardiovascular risk reduction (e.g., GUARD-AF study) Labs/Teams: His work is integrated into Yale’s cardiovascular research programs, focusing on translational studies and collaborative teams such as the: Studies of PCSK9 Inhibition and the Reduction of Vascular Events (SPIRE) PROACC-1 trial for cancer cachexia

• Urologic Oncology
• Kidney Cancer
• Robotic Surgery
• +۳ مورد دیگر

Patrick A. Kenney, MD is an Associate Professor of Urology at Yale School of Medicine, serving as the Chief Ambulatory Physician Executive and Associate Dean for Clinical Affairs. He specializes in urologic oncology, with a focus on kidney cancer surgery, robotic procedures, and the integration of systemic therapies. His administrative roles include leadership in quality improvement, supply chain, and clinical operations across Yale New Haven Health System. Education: MD from Columbia University (2005), residency at Lahey Clinic (2011), and a urologic oncology fellowship at MD Anderson Cancer Center (2013). He is a member of the American Urological Association and American Society of Clinical Oncology. Research interests span kidney cancer management, surgical outcomes, and health system interventions. Key publications address radio-recurrent prostate cancer strategies, pediatric testicular torsion interventions, and private equity's impact on urology practices. Awards include the P.U.R.E. Award and recognition for excellence in teaching and clinical care. His clinical trials include a phase III trial on immunotherapy-based combination therapies for metastatic renal cell carcinoma. Professional activities include roles in the Yale Urology Finance Committee and steering committees for national performance improvement initiatives.

• Medical Oncology
• Lung Cancer
• Mesothelioma
• +۶ مورد دیگر

Professor Michael Lind is a Foundation Professor of Oncology at the University of Hull and Head of the Joint Centre for Cancer Studies . With 35 years in medical oncology (25 as a consultant), he focuses on lung cancer, mesothelioma, oncogeriatrics, and translational research. Chairs National Cancer Registration and Analysis Service lung group for Public Health England Leads projects on physical activity interventions, geriatric assessment, and cancer care equity Supervises 10 completed PhD/MDs and 1 current PhD/MD Research Trends: Recent works span precision oncology (EGFR mutations), healthcare disparities (geographical/socioeconomic), palliative interventions (venting gastrostomy), and pandemic-related cancer care disruptions. Keywords include Lung Cancer, Mesothelioma, Geriatric Assessment, Health Equity, Palliative Care . Labs & Collaborations: Works with the Institute for Clinical and Applied Health Research (ICAHR) and Hull Molecular Imaging Centre (HuMic) .

Michelle Lawمشاهده پروفایل

استادیار

• Cancer cachexia
• Cardiac dysfunction
• Metabolism
• +۶ مورد دیگر

Michelle Law is an Assistant Professor of Nutrition Sciences in the Department of Human Sciences and Design at Baylor University, part of the Robbins College of Health and Human Sciences. Her research focuses on cancer-induced cachexia, cardiac dysfunction, metabolism, and calcium handling, utilizing animal models and molecular techniques. PhD in Interdisciplinary Nutrition Sciences – The Ohio State University MS in Medical Dietetics – The Ohio State University Dietetic Internship – The Ohio State University Bachelor’s in Nutrition and Chemistry – Concordia College, Moorhead, MN Dr. Law's research centers on the pathophysiology of cancer cachexia, particularly how cardiac muscle dysfunction and metabolic alterations contribute to disease progression. She investigates altered calcium handling and metabolic adaptations in cardiac tissue, aiming to uncover therapeutic strategies. Her work bridges nutrition, molecular cardiology, and oncology, with a strong emphasis on preclinical models. Her recent publications (2018–2024) highlight a consistent focus on cachexia , cardiac remodeling , and calcium signaling . Articles span topics from leucine supplementation and obesity interactions in cachexia to methodological concerns in preclinical reporting. Her research frequently appears in physiology, nutrition, and cell biology journals, indicating interdisciplinary impact. While no specific scientific awards are listed, her active publication record and independent research program suggest recognition in her field. Dr. Law teaches several advanced nutrition courses, including NUTR 2351, NUTR 4387, NUTR 5355, and NUTR 5356. She leads the Law Laboratory at Baylor, where she conducts research on animal models of disease. There is no public information on grants or student advising, but her role as a principal investigator implies mentorship and funding acquisition. Her laboratory, the Law Laboratory, focuses on molecular and physiological mechanisms of disease, particularly using murine models to study cardiac and metabolic dysfunction in cancer cachexia.

• Public Health
• Epidemiology
• Preventive Medicine
• +۵ مورد دیگر

Prof. Alessandra Casuccio is a Full Professor at the University of Palermo within the Department of Health Promotion, Maternal and Child, Internal Medicine and Specialist Medicine of Excellence 'G. D'Alessandro'. With extensive publications in public health and preventive medicine, she focuses on vaccine hesitancy, chronic disease prevention, and palliative care optimization. Contact: alessandra.casuccio@unipa.it Office hours: Thursdays and Tuesdays 11:00-13:00 at Policlinico via del Vespro, 133 Palermo Research Interests: Her work spans vaccinology (HPV, influenza, SARS-CoV-2), health disparities in migrant populations, palliative care for advanced cancer patients, and Mediterranean diet effects on vascular health. She employs epidemiological modeling and behavioral health analysis across her studies. Publication Trends: Recent articles (2024-2025) examine vaccine co-administration in pregnancy, home palliative care outcomes, and nutritional interventions for chronic disease management. Methodologies include systematic reviews , observational studies , and clinical protocols .

Fergal O'Farrellمشاهده پروفایل

دانشیار

• Molecular Biology
• Genetics
• Cancer Biology
• +۷ مورد دیگر

Fergal O'Farrell is an Associate Professor and research group leader at the University of Bergen's Department of Biological Sciences. His work focuses on modeling human cancer progression using Drosophila melanogaster with particular emphasis on Ret proto-oncogene signaling and epithelial integrity mechanisms. He received his Ph.D. in Cell and Molecular Biology from Karolinska Institute (2008) following research on Drosophila peripheral nervous system development. Ph.D. in Cell and Molecular Biology, Karolinska Institute (2008) Postdoctoral work at Wenner Gren Institute/Stockholm University Subsequent research at Oslo Cancer Institute Dr. O'Farrell's research investigates: Metastatic mechanisms in Drosophila Ret-tumor models LKB1's contextual oncogene behavior through vesicle trafficking Host autophagy's role in tumor growth and organ wasting Non-autonomous signaling between tumor cells and surrounding tissue Development of cancer prevention strategies through microenvironment manipulation Functional orthology between fly and human disease genes His research trends indicate strong focus on: Autophagy's dual role in tumor progression Receptor Tyrosine Kinase signaling pathways Genetic and pharmacological interventions in cancer models Translational applications of Drosophila research Scientific support includes: Norwegian Cancer Society personal funding CanCell SFF Center of Excellence resources Norwegian Research Council grant (2021) Teaching responsibilities at BIO include MOL200 Biochemistry and MOL213 Developmental Genetics . His lab maintains active collaborations through RDMM-Europe for Peutz-Jeghers syndrome research.

Lydia Matesicمشاهده پروفایل

دانشیار

• Stem Cells & Developmental Biology
• Biology of Cellular Stress
• Molecular Biology
• +۳ مورد دیگر

Lydia Matesic is an Associate Professor in the Department of Biological Sciences at the University of South Carolina , affiliated with the McCausland College of Arts and Sciences. Her research focuses on the functional roles of ubiquitin ligases ITCH and WWP1 in maintaining cellular homeostasis under stress conditions, with implications in autoimmunity, inflammation, cancer, and cardiovascular biology. Expertise in Stem Cells & Developmental Biology Specialized in Biology of Cellular Stress and ubiquitin-mediated signaling Leadership as Director of the Cardiovascular Technology Program Her research explores how ITCH and WWP1 regulate protein turnover in immune cells and cardiac tissues, contributing to diseases like inflammatory bowel disease, cancer, and cardiac arrhythmias. Key findings include ITCH's role in inflammatory barrier maintenance and WWP1's involvement in age-associated cardiac dysfunction. Recent publications highlight investigations into: WWP1's role in myocardial aging and breast cancer therapy ITCH's regulation of hematopoietic stem cells and intestinal epithelial homeostasis Modulation of inflammatory signaling pathways via ubiquitin-editing enzymes Development of fetal lung organoid models for interstitial lung disease Lydia's work bridges molecular mechanisms with translational applications in chronic diseases, though no scientific awards or student advisement details are explicitly listed.

Georgios Mavropaliasمشاهده پروفایل

پژوهشگر ارشد

• Eccentric Exercise
• Exercise Medicine
• Chronic Disease Management
• +۷ مورد دیگر

Dr. Georgios Mavropalias is a Post-Doctoral Research Fellow at Edith Cowan University's School of Medical and Health Sciences. His research focuses on eccentric exercise interventions for chronic diseases, particularly cancer and neurological conditions, with expertise in biochemical analyses, muscle architecture, and data visualization. Education: PhD in Exercise Science (ECU, 2020), MSc in Sports Science (Sweden, 2015), BSc in Physical Education (Greece, 2012). His work emphasizes translating exercise into clinical medicine, including telehealth applications for multiple sclerosis and prostate cancer. Key areas include muscle adaptation mechanisms, exercise-induced biomarker responses, and home-based intervention efficacy. He has supervised PhD projects on eccentric exercise in aging populations and workplace health. Recent publications highlight telehealth exercise delivery systems, eccentric training's impact on muscle mass/strength, and exercise's role in mitigating cancer treatment side effects. His research bridges clinical and physiological insights to optimize health outcomes across diverse populations.

• Protein Interaction Networks
• Microbe-Host Interactions
• Systems Biology
• +۴ مورد دیگر

Prof. Dr. Pascal Falter-Braun is a pioneering academic in network biology, serving as Director of the Institute for Network Biology at Helmholtz Munich and Chairholder for Microbe-Host Interactions at LMU Munich. His work focuses on mapping and analyzing protein interaction networks to understand disease mechanisms and develop therapeutic strategies. Research Interests: Decoding how biochemical networks interpret genetic information into phenotypes Investigating microbe-host interactions in obesity-related metabolic disorders and cancer cachexia Applying AI/Deep Learning for pharmacological intervention discovery Systematic mapping of molecular interactions via high-throughput robotics Integrating population genetics with network analysis for disease prevention Developing mechanistic validation pipelines for network predictions Scientific Achievements: ERC Consolidator Grant recipient (2015) Leader in SARS-CoV-2 contactome mapping Established foundational frameworks for multi-layer network analysis Created high-throughput pipelines for protein interaction studies Key contributor to phytohormone network understanding His interdisciplinary approach combines experimental biology, bioinformatics, and machine learning to identify genetic vulnerabilities and pharmacological targets. The institute’s work spans from basic network principles to translational applications for complex diseases.